Finally, anti-diabetic medication might also influence the cognitive status of persons with T2DM; particularly metformin, glucagon-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 inhibitors have been suggested to potentially exert neuroprotective effects [35]. Here, GLP1R is linked to type 2 diabetes mellitus.